United Therapeutics Corp (NASDAQ:UTHR)

183.46
Delayed Data
As of May 27
 +0.96 / +0.53%
Today’s Change
84.63
Today|||52-Week Range
190.29
+41.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues743.2M914.1M1.1B1.3B
 
 
 
 
 
Cost of Goods Sold68.4M92.2M99.9M93.6M
 
 
 
 
 
Depreciation And Amortization20.5M27.1M31.3M32.2M
 
 
 
 
 
 
Operating ExpensesGross Income654.3M794.8M985.9M1.2B
 
 
 
 
 
General Expenses344.2M368.3M693.4M623.8M
 
 
 
 
 
Research And Development180.0M173.4M299.3M242.5M
 
 
 
 
 
Total Operating Expenses433.1M487.6M824.5M749.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income310.1M426.4M292.5M538.8M
 
 
 
 
 
Extraordinary Credit0.0033.0M210.0K--
 
 
 
Extraordinary Charge0.00-6.8M0.00-1.1M
 
 
 
Pre-Tax Equity Earnings-119.0K-143.0K0.00--
 
 
 
Interest Expense On Debt22.2M17.5M18.1M17.6M
 
 
 
 
 
Other Expenses7.1M866.0K425.0K5.1M
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income299.1M440.7M278.9M525.2M
 
 
 
 
 
Income Taxes-81.9M-136.2M-104.3M-185.1M
 
 
 
 
 
Discontinued Operations7.0K0.000.000.00
 
 
Extraordinary Items618.0K0.000.000.00
 
 
Net Income217.3M304.4M174.6M340.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS57.2M52.1M50.1M48.2M
 
 
 
 
 
Shares To Calculate EPS Diluted59.4M53.3M53.2M54.2M
 
 
 
 
 
 
Earnings Per ShareEPS$3.67$5.71$3.28$6.28
 
 
 
 
 
EPS Diluted$3.66$5.71$3.28$6.28
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account